Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Recruiting · NCT07159750 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute
View the official record on ClinicalTrials.gov →Interventions studied
CGRP antibody or gepant
What this trial is about
The goal of this observational study is to evaluate clinical differences in patients who received preventive treatment with medication targeting calcitonin gene-related peptide (CGRP) or its receptor: monoclonal antibodies (erenumab, galcanezumab, fremanezumab, eptinezumab) or gepants (rimegepant, atogepant) during a 2-year period observation phase.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Migraine diagnosis according to ICHD-III.
- Prescription of erenumab, galcanezumab, fremanezumab, eptinezumab, atogepant or rimegepant according to prescriptor criteria and reimbursement criteria according to local regulations.
- Signature of informed consent.
Exclusion criteria
- Presence of headache different from migraine.
- Active severe psychiatric condition or cognitive impairment which may affect the ability to consent patient's participation in the study.
Where it is running
26 locations listed across 1 US state.
- University of Miami, Miller School of Medicine - Miami, Florida, United States
- Hospital General Universitario de Albacete - Albacete, Spain
- Charité Universitätsmedizin Berlin - Berlin, Germany
- FLENI - Buenos Aires, Argentina
- Neuroclinic Norway - Lillestrøm, Norway
- Hospital Santa Maria Lisbon - Lisbon, Portugal
- University of L'Aquila - L’Aquila, Italy
- Fundación Jiménez Díaz - Madrid, Spain
- Hospital Universitario Gregorio Marañón - Madrid, Spain
- La Paz University Hospital - Madrid, Spain
- Neuromedica - Medellín, Colombia
- Mersin University - Mersin, Turkey (Türkiye)
- University of Modena and Reggio Emilia - Modena, Italy
- LMU University Hospital - München, Germany
- National Neurological Institute C. Mondino Foundation - Pavia, Italy
- IRCCS San Raffaele - Roma, Italy
- Special Hospital for Orthopedics and Rehabilitation "Martin Horvat" Rovinj-Rovigno - Rovinj, Croatia
- Pontificia Universidad Católica de Chile - Santiago, Chile
- Wrocław Medical University - Wroclaw, Poland
- Hospital Clínico Universitario Lozano Blesa - Zaragoza, Spain
- Germans Trias i Pujol Hospital - Badalona, Barcelona, Spain
- Vall d'Hebron University Hospital - Barcelona, Barcelona, Spain
- Hospital Universitari de Bellvitge - L'Hospitalet de Llobregat, Barcelona, Spain
- Fundació Sanitària Mollet - Mollet del Vallès, Barcelona, Spain
- Hospital de Viladecans - Viladecans, Barcelona, Spain
- Universiti Putra Malaysia - Serdang, Selangor, Malaysia